A prolonged disease trajectory complicates “survivor” identity, particularly when remission follows transplant yet later ...

Human cohort studies and meta-analyses have not shown increased incidence of common differentiated thyroid cancers with GLP-1 receptor agonist exposure. Rodent C-cell tumor signals underpin the boxed ...

The FDA has accepted a sNDA for Ameluz topical gel, used in combination with the RhodoLED red-light lamp series, for superficial basal cell carcinoma treatment.

With this decision, Optune Pax becomes the first new FDA-approved treatment for locally advanced pancreatic cancer in decades. For patients and families navigating this diagnosis, the addition of a ...

Colleen Mabasa, a patient with multiple myeloma, sat down with CURE for an interview to discuss how she pursued chimeric antigen receptor (CAR)-T cell therapy, navigated insurance and logistical ...

While cranial radiation therapy (CRT) remains a major risk factor — with high doses of radiation showing a hazard ratio of ...

Chris Draft said patients with lung cancer and their caregivers can regain control after diagnosis by showing up, staying ...

The FDA has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneous, chemo-free ...

Scalp cooling during chemotherapy can be pivotal for AYA identity preservation and psychosocial functioning, facilitating ...

Cancer is a major thief. The disease can take your hair, your fingernails, your energy, your appetite. The list goes on and ...

FDA approved a PD-L1 companion test to identify patients with ovarian, fallopian tube or primary peritoneal cancer who may receive first-line Keytruda. The U.S. Food and Drug Administration (FDA) has ...

The FDA approved protocol updates to a tasquinimod trial in myelofibrosis, allowing broader enrollment and combination use ...